DRKY: VistaShares Target 15 DRUKMacro Distribution ETF
ETF Education Report: VistaShares Target 15 DRUKMacro Distribution ETF (DRKY)
What this ETF is trying to do
The VistaShares Target 15 DRUKMacro Distribution ETF (ticker: DRKY) is an exchange-traded fund listed on the NYSE. This ETF holds a collection of different companies. Based on the provided data, its top holdings include Natera Inc (30.36%) and Insmed Inc (8.38%). Because the list provided is partial, these are considered "Top Holdings" rather than all the companies in the fund. Please remember that holdings can change over time.
What the numbers show
When looking at how an ETF performs, it is important to look at two different types of returns:
• Price Return: This measures only the change in the share price. For this ETF, the year-to-date (YTD) price return is approximately 3.18%.
• Total Return: This measures the overall change, including both the share price and any cash distributions paid out. The YTD total return for this ETF is approximately 14.14%.
There is a big difference between these two numbers. The total return is higher because it includes the cash paid to investors.
Income and distribution explanation
This ETF focuses on providing cash to investors through distributions. The current distribution yield is approximately 12.73%. This means the amount of cash distributed relative to the ETF's price is quite high. Over the last 12 months, there were 11 distributions, and they usually happen on a monthly basis. Most of these payments have occurred on Mondays.
It is important to understand that a high distribution yield does not mean the investor earned that same percentage as total return. While distributions provide cash income, they are separate from the movement of the share price.
NAV erosion explanation
"NAV erosion" is a term used to describe when the value of the underlying assets in a fund decreases. While some investors worry about this when they see high payouts, there is no "severe erosion-risk flag" for this ETF. The current erosion score is withheld because there is not enough verified price history available to provide a score.
Pros
• The ETF has provided a significant YTD total return of approximately 14.14%.
• It offers a high distribution yield, which may provide regular cash income to investors.
Cons
• The income rating grade is a "D," which suggests the income profile may have specific characteristics investors should study.
• The YTD price return (3.18%) is much lower than the total return, meaning most of the gains came from distributions rather than the share price going up.
Beginner takeaway
When looking at DRKY, it is vital to distinguish between the share price and the cash distributions. A high distribution yield can look very attractive, but you should always check the total return to see how the fund is performing overall. High yields alone can sometimes be misleading if they are not paired with stable share prices.
Top Holdings
Structured portfolio holdings supplied by the ETF data provider. These figures are not generated by the AI article.
| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | NATERA INC | NTRA | 30.36% |
| 2 | INSMED INC | INSM | 8.38% |
| 3 | n/a | TSM | 6.64% |
| 4 | YPF SA ADR | YPF | 6.05% |
| 5 | SEA LTD ADR | SE | 5.13% |
| 6 | BBB FOODS INC CLASS A | TBBB | 4.94% |
| 7 | ROKU INC CLASS A | ROKU | 4.37% |
| 8 | TEVA PHARMACEUTICAL INDUSTRIES LTD ADR | TEVA | 3.70% |
| 9 | WOODWARD INC | WWD | 3.66% |
| 10 | NEWAMSTERDAM PHARMA CO NV | NAMS | 2.94% |